Most Recent
Aldi offered $150,000 to settle MoroccanOil dispute
Discount supermarket chain Aldi offered $150,000 to end a lawsuit brought by the maker of the popular MoroccanOil line of hair products, a court judgment revealed Tuesday.
ObjectiVision wraps up IP trial against University of Sydney
Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and contract dispute with the University of Sydney, saying in closing submissions that the school had run a "curious" case. 
Microsoft wins $2.8M judgment for violations of Windows IP
Microsoft has won a $2.8 million judgment against a Melbourne computer retailer for violating the intellectual property for its Windows 7 software.
Hytera ordered to hand over source code in Motorola IP dispute
Chinese tech company Hytera Communications Corporation has been ordered to hand over source code for all radio devices at the heart of a international patent dispute with Motorola Solutions.
Alphapharm says Sanofi patent amendment should doom injunction bid
Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.
Fonterra denied strict confidentiality regime in Bega trade mark dispute
A judge has denied a bid for a strict regime for dealing with confidential information in a lawsuit between cheese giants Fonterra and Bega over alleged violations of the terms of a trade mark licensing agreement.
Apotex threatened to infringe Cialis patents, court finds
A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.
Millennium wins injunction against Juno over generic cancer drug
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Guard rail maker wins ruling invalidating rival’s patent
A maker of guard rails used on highways has won a judgment invalidating a rival's patent, with a judge finding the patent lacks novelty.